Why FMC’s governance reforms matter for shareholders

FMC (FMC) has drawn fresh attention after proposing governance changes ahead of its April 28, 2026 annual meeting, including removing supermajority voting and giving investors holding 25% the ability to call special meetings.

For current and potential shareholders, these proposals focus attention on how much influence investors have over board decisions, future corporate actions, and the company’s overall approach to accountability and corporate control.

FMC’s proposed governance changes arrive after a tough period for investors, with a 1-year total shareholder return decline of 65.33% and multi-year losses, even as the 90-day share price return of 4.58% hints at stabilising momentum.

If this kind of governance reset has you rethinking where capital could work harder, it may be worth widening your search and checking out 20 top founder-led companies

With FMC shares down sharply over 1 year but trading at a reported 32% discount to one intrinsic value estimate, you need to ask: is this a reset that leaves upside on the table, or is the market already pricing in any recovery?

Most Popular Narrative: 23.1% Undervalued

FMC's most followed valuation narrative puts fair value at about $18.12 per share, compared with the last close of $13.93. This raises clear questions about what drives that gap.

Ongoing cost transformation, including lower manufacturing costs for key products like Rynaxypyr and benefits from 2024 to 2025 restructuring, creates durable COGS reductions and improved fixed cost absorption. This serves as a catalyst for sustainable EBITDA and net margin improvement. The shift away from direct commercial operations in India to a lower risk, B2B supply model frees up cash for debt reduction, enhances the balance sheet, and enables redeployment of capital toward high value innovation and growth portfolios, which is expected to have a positive impact on net earnings over the long term.

Want to see what kind of revenue path and margin rebuild is baked into that value gap narrative? The story hangs on a specific earnings bridge and a future profit multiple that looks very different from today.

Result: Fair Value of $18.12 (UNDERVALUED)

However, this hinges on execution. Ongoing pricing pressure and elevated net leverage near 4.3x EBITDA could quickly challenge the repair story analysts are counting on.

Next Steps

With both risks and potential rewards in play, do you want to rely on headlines or your own judgment? Act now by weighing FMC's 3 key rewards and 2 important warning signs

Ready to hunt for your next investment idea?

Do not stop your research with FMC alone, broaden your watchlist now or you risk missing other businesses that might fit your goals even better.

• Target resilient income by scanning for companies with strong yields and durable payouts using the 13 dividend fortresses.
• Spot potential value opportunities early by reviewing companies flagged in the screener containing 25 high quality undiscovered gems.
• Prioritise capital preservation by focusing on businesses highlighted in the 72 resilient stocks with low risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.